A network-based drug repurposing method via non-negative matrix factorization.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34875000.
- Also identified by DOI 10.1093/bioinformatics/btab826 and PMC identifier 8825773.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Drug repurposing is a potential alternative to the traditional drug discovery process. Drug repurposing can be formulated as a recommender system that recommends novel indications for available drugs based on known drug-disease associations. This article presents a method based on non-negative matrix factorization (NMF-DR) to predict the drug-related candidate disease indications. This work proposes a recommender system-based method for drug repurposing to predict novel drug indications by integrating drug and diseases related data sources. For this purpose, this framework first integrates two types of disease similarities, the associations between drugs and diseases, and the various similarities between drugs from different views to make a heterogeneous drug-disease interaction network. Then, an improved non-negative matrix factorization-based method is proposed to complete the drug-disease adjacency matrix with predicted scores for unknown drug-disease pairs. The comprehensive experimental results show that NMF-DR achieves superior prediction performance when compared with several existing methods for drug-disease association prediction. The program is available at https://github.com/sshaghayeghs/NMF-DR. Supplementary data are available at Bioinformatics online.
Medical subject headings
- Computational Biology
- Drug Repositioning